Category

Cohort News

LensGen® Closes $10 Million Financing and Welcomes James V. Mazzo to its Board of Directors

LensGen, Inc., an ophthalmic medical device company and developer of Juvene®, a disruptive fluid-optic intraocular lens (IOL) for cataract and presbyopia treatment, announces the initial Closing of a $10 million of the $20 million Bridge Financing. The company is also pleased to announce the election of James (Jim) Mazzo to its Board of Directors.
Read More →

Sentien Biotechnologies Announces Open IND in Phase 1/2 Trial of SBI-101 for Patients with COVID-19

Sentien Biotechnologies, Inc., a clinical-stage biotechnology company developing novel approaches to cell therapy, today announced that the U.S. Food and Drug Administration (FDA) has approved the company’s Investigational New Drug (IND) application for the evaluation of Sentien’s lead asset, SBI-101, for the treatment of severe COVID-19.
Read More →

HD Medical Awarded FDA Clearance For HD Steth

//
Categories
HD Medical, Inc. of Silicon Valley today announces that its flagship product, HD Steth, has received FDA clearance for all three product classification codes of DQD, DQC and DPS for Electronic Stethoscope, Phonocardiograph and Electrocardiograph combined into one device. HD Steth utilizes cutting-edge AI technology to enable clinicians to perform advanced cardiac evaluation at the point-of-care to save time and lives.
Read More →

Forest Devices Launches Collaboration With Alberta Health Services

Medical technology pioneer Forest Devices, Inc. (FDI) today announced a commitment to improve healthcare delivery for stroke patients in Alberta, forming a collaboration with Alberta Health Services (AHS) to evaluate and test technologies that can improve patient outcomes and health system performance by empowering emergency first responders to make informed decisions regarding care for stroke patients.
Read More →

Medable Partners With Datavant to Simplify Integration of Data Sources for Decentralized Clinical Trials

Medable Inc., the leading software provider for decentralized clinical trials, and Datavant, the leader in helping healthcare organizations safely connect their data, today announced a partnership that will help clinical trial teams easily integrate multiple data sources to accelerate decentralized trial design, recruitment and data management.
Read More →